CVE-2018-14786
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3…
Published 8 y ago · modified 4 mo ago · JSON
Summary
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Exploit prediction (EPSS)
2.94% probability of exploitation in the next 30 days, higher than 87% of all scored CVEs.
CVSS scores
| Assigned by | Version | Score | Vector |
|---|---|---|---|
| NVD | 3.0 | 9.4 | CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H |
| NVD | 2.0 | 7.5 | AV:N/AC:L/Au:N/C:P/I:P/A:P |
Affected products
- Becton, Dickinson and Company Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA
Classification
- Weakness
- CWE-287 Improper Authentication
References
- securityfocus.com /bid/105147 · vdb-entry, x_refsource_BID, x_transferred
- bd.com /en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-p · x_refsource_CONFIRM, x_transferred
- ics-cert.us-cert.gov /advisories/ICSMA-18-235-01 · x_refsource_MISC, x_transferred
Sources
- CVE List: CVE-2018-14786
- NVD: CVE-2018-14786
vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.